Tralokinumab (IL13) - Research Grade Biosimilar
Product Specifications
Background
Tralokinumab is under investigation for the treatment of Alopecia Areata. Tralokinumab has been investigated for the treatment of Asthma.
Immunogen
Homo sapiens / IL13 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=10-192
Fragment
IgG4-lambda
NCBI Organism
Homo sapiens
Other Product Names
CAT-354
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS156860-01 0.05 mg
Recombinant Cutibacterium acnes cAMP factor 1 protein, N-His Tag
Ask
View Details 
MBS156860-02 0.1 mg
Recombinant Cutibacterium acnes cAMP factor 1 protein, N-His Tag
Ask
View Details MBS156860-03 5x 0.1 mg
Recombinant Cutibacterium acnes cAMP factor 1 protein, N-His Tag
Ask
View Details MBS6255201-01 0.1 mL
Papilloma Virus, Human, Type 16, E7 Protein (HPV) (MaxLight 550)
Ask
View Details